No abstract available
MeSH terms
-
Adult
-
Anti-Allergic Agents / adverse effects
-
Anti-Allergic Agents / therapeutic use*
-
Biological Products / adverse effects
-
Biological Products / therapeutic use*
-
Chronic Disease
-
Colitis, Ulcerative / diagnosis
-
Colitis, Ulcerative / drug therapy*
-
Colitis, Ulcerative / immunology
-
Crohn Disease / diagnosis
-
Crohn Disease / drug therapy*
-
Crohn Disease / immunology
-
Female
-
Humans
-
Immunoglobulin E / immunology
-
Male
-
Middle Aged
-
Omalizumab / adverse effects
-
Omalizumab / therapeutic use*
-
Psoriasis / diagnosis
-
Psoriasis / drug therapy*
-
Psoriasis / immunology
-
Retrospective Studies
-
Spondylitis, Ankylosing / diagnosis
-
Spondylitis, Ankylosing / drug therapy*
-
Spondylitis, Ankylosing / immunology
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
Tumor Necrosis Factor-alpha / immunology
-
Urticaria / diagnosis
-
Urticaria / drug therapy*
-
Urticaria / immunology
-
Young Adult
Substances
-
Anti-Allergic Agents
-
Biological Products
-
Tumor Necrosis Factor-alpha
-
Omalizumab
-
Immunoglobulin E